Analysts expect Aligos Therapeutics, Inc. to report revenue of 4.59 M for Q3 26, against a range of 4.39 M to 4.79 M. The most recent reported quarter, Q2 26, came in at 27.78 M, a 7.9% beat against the 25.74 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.27 M | 629,000.00 | 311,000.00 | 965,000.00 | 741,000.00 | 169,000.00 | 2.83 M | 27.78 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 335,859.52 | 458,257.65 | 502,780.09 | 425,239.68 | 486,599.69 | 463,376.39 | 252,262.03 | 27.09 M | 4.79 M | 599,373.16 | 230,530.99 | 246,434.36 | 4.09 M | 725,385.23 | 4.72 M | 9.32 M | ||||||||||
| Low Estimate | 289,930.88 | 387,199.51 | 472,934.91 | 396,887.00 | 455,105.31 | 388,987.21 | 236,935.47 | 24.40 M | 4.39 M | 549,737.34 | 198,779.21 | 215,209.24 | 3.50 M | 637,001.73 | 4.30 M | 7.84 M | ||||||||||
| Consensus Estimate | 312,895.20 | 422,728.58 | 487,857.50 | 411,063.34 | 470,852.50 | 426,181.80 | 244,598.75 | 25.74 M | 4.59 M | 574,555.25 | 214,655.10 | 230,821.80 | 3.79 M | 681,193.48 | 4.51 M | 8.58 M |
Analysts expect Aligos Therapeutics, Inc. to report earnings per share of -2.30 for Q3 26, against a range of -2.50 to -2.10. The most recent reported quarter, Q2 26, came in at -0.14, a 86.8% beat against the -1.06 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.07 | -13.08 | -2.11 | -1.53 | -3.04 | -1.91 | -2.21 | -0.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -2.14 | -2.19 | -2.94 | -2.13 | -1.66 | -2.37 | -2.18 | -1.00 | -2.10 | -1.67 | -1.63 | -1.52 | -2.20 | -1.86 | 0.45 | 0.01 | ||||||||||
| Low Estimate | -2.32 | -2.55 | -3.16 | -2.27 | -1.90 | -2.73 | -2.42 | -1.12 | -2.50 | -1.99 | -1.85 | -1.66 | -2.54 | -2.20 | 0.41 | 0.01 | ||||||||||
| Consensus Estimate | -2.23 | -2.37 | -3.05 | -2.20 | -1.78 | -2.55 | -2.30 | -1.06 | -2.30 | -1.83 | -1.74 | -1.59 | -2.37 | -2.03 | 0.43 | 0.01 |